Farhana Ferdousi Selected Research

3-methylquercetin

1/2020	Effects of Isorhamnetin in Human Amniotic Epithelial Stem Cells in vitro and Its Cardioprotective Effects in vivo.
1/2020	Global Gene Expression Profiling Reveals Isorhamnetin Induces Hepatic-Lineage Specific Differentiation in Human Amniotic Epithelial Cells.
12/2019	Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells.
11/2019	Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Farhana Ferdousi Research Topics

Disease

4	Fibrosis (Cirrhosis) 01/2020 - 11/2019
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
1	Cerebral Small Vessel Diseases 02/2022
1	Stroke (Strokes) 02/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2022
1	Cerebral Hemorrhage 02/2022
1	Lacunar Stroke 02/2022
1	Hemorrhage 02/2022
1	Alopecia (Baldness) 01/2022
1	COVID-19 12/2021
1	Depressive Disorder (Melancholia) 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Pathologic Neovascularization 01/2020
1	Dementia (Dementias) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Insulin Resistance 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Neuroblastoma 01/2020
1	Cognitive Dysfunction 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Non-alcoholic Fatty Liver Disease 11/2019

Drug/Important Bio-Agent (IBA)

4	3-methylquercetinIBA 01/2020 - 11/2019
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Antidepressive Agents (Antidepressants)IBA 12/2021 - 01/2019
2	FlavonoidsIBA 01/2020 - 12/2019
2	Biological ProductsIBA 01/2020 - 12/2019
1	Phosphodiesterase 3 InhibitorsIBA 02/2022
1	Clopidogrel (Plavix)FDA Link 02/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Minoxidil (Rogaine)FDA LinkGeneric 01/2022
1	AcidsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 12/2021
1	LuteolinIBA 01/2021
1	Angiotensin IIIBA 01/2020
1	cornin iridoidIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Sirtuin 1IBA 01/2020
1	QuercetinIBA 12/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	CytokinesIBA 01/2019
1	caffeoylquinic acidIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019

Therapy/Procedure

3	Therapeutics 02/2022 - 01/2020